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Abstract: Successful and sustainable intervention against
human helminthiases depends on optimal utilisation of
available control measures and development of new tools
and strategies, as well as an understanding of the
evolutionary implications of prolonged intervention on
parasite populations and those of their hosts and vectors.
This will depend largely on updated knowledge of
relevant and fundamental parasite biology. There is a
need, therefore, to exploit and apply new knowledge and
techniques in order to make significant and novel gains in
combating helminthiases and supporting the sustainabil-
ity of current and successful mass drug administration
(MDA) programmes. Among the fields of basic research
that are likely to yield improved control tools, the Disease
Reference Group on Helminth Infections (DRG4) has
identified four broad areas that stand out as central to
the development of the next generation of helminth
control measures: 1) parasite genetics, genomics, and
functional genomics; 2) parasite immunology; 3) (verte-
brate) host–parasite interactions and immunopathology;
and 4) (invertebrate) host–parasite interactions and
transmission biology. The DRG4 was established in 2009
by the Special Programme for Research and Training in
Tropical Diseases (TDR). The Group was given the
mandate to undertake a comprehensive review of recent
advances in helminthiases research in order to identify
notable gaps and highlight priority areas. This paper
summarises recent advances and discusses challenges in
the investigation of the fundamental biology of those
helminth parasites under the DRG4 Group’s remit
according to the identified priorities, and presents a
research and development agenda for basic parasite
research and enabling technologies that will help support
control and elimination efforts against human helminthi-
ases.
Introduction: Helminth Biology and the
Prevention and Control of Helminth Infection
This century has seen a substantial global impetus towards
raising public and scientific awareness of neglected tropical
diseases (NTDs) in general and helminthiases in particular, and
a great concerted effort has been made to elevate their political
and funding profiles [1,2]. As a result, the control of their
morbidity and transmission has become highly important in the
agenda of many public–private partnerships (PPPs) and national
governments. The reasons for this, as well as the descriptions of
the main ongoing initiatives against human helminthiases, are
described in other reviews of this collection [3,4]. Such initiatives
have been partly fuelled by, or have themselves facilitated, much
advancement in our understanding of the biology and epidemi-
ology of the helminthiases they aim to control, and implementa-
tion has been followed by considerable success in many endemic
areas. Sustaining this success and extending it to other more
challenging situations brings a new set of questions, for which basic
and operations research is urgently needed. In the context of this
paper (and others in this collection), operations research is used to
refer to the utilisation of relevant biological knowledge and
appropriate and updated technologies by large-scale parasite
control initiatives for the deployment of effective and optimal
strategies aimed to reduce the parasite burden, transmission, and
morbidity of poverty-related infectious diseases in general and
helminthiases in particular.
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human helminthiases depends on optimal utilisation of available
control measures and development of new tools and strategies, as
well as on an understanding of the evolutionary implications of
prolonged intervention on parasite populations and those of their
hosts and vectors. This will depend largely on updated knowledge
of relevant and fundamental parasite biology. On the one hand, it
is reassuring that current interventions are mostly based on the
application of past research, highlighting the important role that
basic and operations research has indeed played in control
programmes [3]. On the other, it is of concern that the research
and development (R&D) agenda is not moving ahead at the pace
required by the renewed impetus against helminth diseases. This is
best illustrated by the reliance on single or very few drugs, most of
which have been in use for many years (decades in some cases),
none of which are highly efficacious in all settings and for all
helminth species, and for which optimal dosages, combinations
with other pharmaceuticals, and frequency of administration have
not yet been established [5]. Additionally, more often than not,
their mode of action is incompletely understood. For a recent
review on unresolved issues in the pharmacology of anthelmintics
we refer the readers to the authoritative paper of Geary et al. [6].
Likewise, assessment of infection at the individual and population
levels relies on diagnostic tests that are in some cases older than the
drugs, and whose diagnostic performance may not be the most
appropriate, as parasite load and prevalence decline upon
intervention [7]. Although more than one-third of the world’s
population is plagued by helminthiases [8], very little is understood
in terms of host–parasite interactions and intra- and interspecific
parasite interactions.
One of the main factors associated with the existence of research
gaps in basic helminth biology is the understandable priority given
to applied activities at the expense of basic research. ‘‘Under-
standable’’ because the imperative of controlling helminth
infections, or relieving the morbidity associated with these
infections, has led to the prioritization of deploying the
interventions, and particularly delivering the drugs via mass drug
administration (MDA); treating an increasing number of popula-
tions at risk, and ensuring high coverage. Since this has been
effective in many cases, there has been a tendency to place support
for more fundamental research on the back burner. However, as
already discussed in this collection [5], reliance on MDA with a
handful of drugs, and lack of knowledge of how parasite
population and genetic structure will change under chemothera-
peutic pressure, makes the control programmes potentially
vulnerable to the development of drug resistance, particularly
when few or no alternative drugs exist or are being developed
(reviewed in [6,9]). Furthermore, there is the potential for
unintended consequences of MDA and other current or future
interventions stemming from the poorly understood dynamics of
host–parasite interactions, parasite–parasite interactions, and the
changes that altering the parasite abundance (infection intensity
and prevalence) of targeted species may have on those interactions.
Not only will interventions have epidemiological effects, but they
also will have evolutionary implications. In addition to the possible
development of anthelmintic resistance, any measure that reduces
the fitness of the parasite population in terms of its survival,
reproduction, and/or transmissibility, will exert some selective
pressure to which the parasites may respond adaptively [10].
Basic biology research should inform and underpin the
prevention and control of helminth infection. The possible list of
basic research issues is very long indeed and other authors before
us have compiled extensive research agendas for specific infections
[11,12], but there are four broad areas that stand out as central to
the development of the next generation of helminth control
measures: 1) parasite genetics, genomics, and functional genomics;
2) parasite immunology; 3) (vertebrate) host–parasite interactions
and pathogenesis; and 4) (invertebrate) host–parasite interactions
and transmission biology. Box 1 lists the abbreviations used in this
paper. We summarise recent advances and identify challenges in
the investigation of the fundamental biology of helminth parasites
of humans according to these four priority areas (Box 2), and
present an R&D agenda for basic parasite research and enabling
technologies that will help support control and elimination efforts,
according to the deliberations of the Disease Reference Group on
Helminth Infections (DRG4), established in 2009 by the Special
Programme for Research and Training in Tropical Diseases
(TDR) . The priority research areas identified are all grounded in
a continuous effort to improve and update knowledge of helminth
basic biology and to translate such knowledge into optimised
intervention tools, and in so doing help to bridge the gap between
the bench, clinical and population-based research studies, and
operational programmes.
Current Advances in Basic Research on Helminth
Biology and Future Challenges
1) Parasite Genetics, Genomics, and Functional Genomics
The onset of the genomics revolution has raised hopes for the
development of applications in the field of human health. New
tools addressing pathogens and their vectors have increased our
understanding of evolutionary processes and the delicate interplay
between parasites and hosts and with their environment. We can
expect important technological advances, not only in new
diagnostics, therapeutics, and vaccine development, but also in
our understanding of disease mechanisms, host–parasite interac-
tions, and transmission biology [13,14]. In this regard, a
comparison of helminthiases with malaria may be helpful in
highlighting how these areas of research can transform a whole
field. Malaria genomics over the past decade has reinvigorated
drug and vaccine development, enabling the development of more
Box 1. List of Abbreviations
BLAST, basic local alignment search tool
DRG4, Disease Reference Group on Helminth Infections
dsRNA, double-stranded RNA
ES, excretory-secretory
HUVE, human umbilical vein endothelial cell proliferation
IFN-c, gamma interferon
IFNGR1, IFN-c receptor 1 gene
IL, interleukin
LECs, lymphatic endothelial cells
LF, lymphatic filariasis
L3, infective third-stage larvae
MDA, mass drug administration
mf, microfilariae
NCC, neurocysticercosis
NTDs, neglected tropical diseases
OCP, Onchocerciasis Control Programme in West Africa
PPP, public-private partnership
R&D, research and development
RNAi, RNA interference
STHs, soil-transmitted helminthiases
TDR, Special Programme for Research and Training in
Tropical Diseases
Th, T helper
WHO, World Health Organization
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elimination efforts [15].
The recent research landscape for helminth parasites has been
dominated by rapid progress in genome sequencing of several
nematode and trematode parasites of significance to human
disease. Today, the genome sequences of 22 species of helminths
that either infect humans, or are closely related parasites, are
completed or under way, including most or all of the significant
soil-transmitted helminthiases (STHs), schistosomes, and filarial
species [13]. A comprehensive genome analysis has been published
for several of them, including the lymphatic filarial nematode
Brugia malayi [16], and the blood flukes Schistosoma mansoni [17] and
S. japonicum [18]. The recently published draft genome of the
porcine parasite Ascaris suum also provides a comprehensive
resource to study human ascariasis [19]. The cost of sequencing
using second generation technologies is such that obtaining a
genome sequence is no longer prohibitively expensive or seen as a
major barrier or significant investment. Importantly, the genomes
of Loa loa, Wuchereria brancrofti, and Onchocerca volvulus (http://www.
broadinstitute.org/annotation/genome/filarial_worms/MultiHome.
html) now have been sequenced in part as well. However, some
of the available genomes are incomplete, poorly annotated, or
not annotated at all, and there are almost no tools available with
which gene function can be tested directly. Although the current
genome drafts of S. mansoni and S. japonicum achieve 5- to 6-fold
coverage of the entire genome, this includes large numbers of
incontinuous contigs and supercontigs with gaps [20]. Without
annotation and functional genomic tools, the sequence data are
not truly useful, so careful thought should be placed to invest
not only on sequence generation but also on annotation,
capitalising on genome-wide approaches to understand the
structure of parasite populations [21,22]. However, it can also
be argued that a good transcriptomic dataset is more useful for
vaccine/drug screening, requiring substantially less investment
in personnel (annotation expertise), a factor that slows down the
genome sequence annotations. Examples of large transcriptomic
studies from human helminths include those on Necator
americanus [23], S. japonicum [24], Clonorchis sinensis,a n d
Opisthorchis viverrini [25,26], which provide very useful informa-
tion for all the ‘‘omics’’ and discovery of vaccine antigens and
drug targets.
The limited availability of functional genomic tools (with which
gene function can be investigated) for helminths contrasts
markedly with, for example, the situation with several groups of
protozoan parasites (especially Plasmodium spp.), for which the
development of functional genomic tools has accompanied
genome sequencing (for a more detailed explanation of functional
genomic tools in parasite research, see Box 3). This has resulted in
much useful annotation of protozoan parasite genomes, which
have yielded information that has been applied to practical ends,
such as the creation of a comprehensive database containing a list
of all potential drug targets for malaria (http://www.
bioinformatics.org/mdt). Moreover, genome sequencing, accom-
panied by the annotation of protozoan parasite genomes and the
subsequent development of functional genomic tools, has also
enabled the generation of testable gene function hypotheses. The
results of such experimental tests of function are now being applied
to parasite genetic investigation, and drug and vaccine develop-
ment. A similar, genome-driven expansion of schistosome research
is gathering momentum as a result of developments that have
followed the publication of annotated schistosome genomes and
concurrent development of better tools with which those genome
sequences can be utilised (http://www.genedb.org/Homepage/
Smansoni; http://schistodb.net) [27]. However, despite the
significant advances made in genomic, proteomic, and transcrip-
tomic profiles of helminths, these ‘‘-omics’’ are still in the early
developmental stages. Provided that effective functional genomic
tools, similar to those already in use in malaria research, are
developed also for helminths, available genomic data will have a
major impact in the long term to support basic research that is
needed if new treatments are to be developed and current ones
made more effective and sustainable. Notwithstanding the obvious
value of learning from successes with malaria parasites, Toxoplasma
gondii, and other non-metazoan pathogens, the human helminths
are much more complex organisms (e.g., they are diploid, have
reproductive and other organs, nervous systems, etc.); there are
many more species of them; they belong to two completely
unrelated phyla (Platyhelminthes and Nematoda); no cell lines are
available; the developmental cycles cannot be completed in vitro,
and their developmental cycles are not only dissimilar to those of
malaria and other apicomplexans, but they are also generally
dissimilar to each other’s, e.g., A. lumbricoides versus W. bancrofti
versus Echinococcus multilocularis, etc.
Box 2. Five Summary Points for Basic Research
and Enabling Technologies for Helminthiases
N Four areas have been identified in which basic research
can contribute potentially to develop enabling technol-
ogies for successful parasite control. These are:
1) Parasite genetics, genomics, and functional genomics
2) Parasite immunology
3) (Vertebrate) host–parasiteinteractionsandpathogenesis
4) (Invertebrate) host–parasite interactions and transmis-
sion biology
N Genomes of helminth parasites are becoming increas-
ingly available and promise to revolutionise (also
through related advances in transcriptomics and pro-
teomics) the field of helminth biology and help unravel
new targets for control. Without annotation and
functional genomic tools, these data will not be truly
useful to support the search for novel interventions.
Knowledge of how parasite population genetic structure
will change under chemotherapeutic pressure is essen-
tial to understand the evolutionary implications of
intervention.
N Helminths have evolved to evade or subvert powerful,
immune-mediated, host defense mechanisms. However,
the processes that initiate and sustain immune regula-
tion on the one hand, or lead to pathogenesis on the
other, and the effects upon them of prolonged
anthelmintic intervention remain incompletely under-
stood.
N Knowledge of factors controlling host–parasite interac-
tions can ultimately support identification of vulnerable
pathways to be targeted by novel interventions and help
avert unintended consequences of intervention (e.g.,
increased transmission, and/or morbidity).
N Vector/intermediate host–parasite interactions are usu-
ally under-appreciated, though they may hold the key to
many of the epidemiological and evolutionary under-
pinnings of helminth infections with complex life cycles.
Their improved investigation will help support the
deployment of antivectorial control measures and
understand the effects of these measures on parasite
abundance and transmission dynamics.
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which parasite gene expression can be directly investigated has
also been the subject of recent developments. RNA interference
(RNAi, or gene silencing), whereby gene expression is knocked
down (gene-specific double-stranded RNA [dsRNA] triggers
degradation of homologous mRNA transcripts), has been
attempted in several parasitic nematode and trematode species.
The effectiveness of RNAi in helminths (particularly nematodes)
seems to be somewhat variable, especially in nematodes, so it
remains to be seen whether it will be a generally useful technique,
or whether its application will be restricted to a handful of RNAi-
susceptible species [28,29]. For most parasitic nematodes (except-
ing Haemonchus contortus, a parasite of sheep), there are very few
good (and reproducible) examples [30,31]. Having said that,
recent advances have been also made targeting the filarial
nematode B. malayi as it develops in an intermediate host, the
mosquito Aedes aegypti, thus supporting future parasitic nematode
biology and the possibility of identifying and validating novel
anthelmintic drug targets [32]. In contrast to the situation in
nematodes, RNAi in schistosomes seems to be more robust and
reproducible [33] and is currently being used by a number of
groups to elucidate the function of some key proteins and
pathways in these parasites, such as haemoglobin digestion
[34,35], tegument formation, and the biological role of tegumental
proteins [36–39], and advances are being made for S. haematobium
[40]. Additionally, a vector-based RNAi model for S. mansoni has
recently been developed [41,42]. These approaches have helped
identify vaccine/drug candidates, some of which are in various
stages of clinical development, providing examples of how bench
research in a post-genomic era is revealing potential targets for
novel interventions [43].
The alternative means by which gene function can be decreased
is via loss of function mutation. The converse of knock-down of
expression is manipulation of expression by gene knock-in. There
are now several reports of either transient or heritable transgenesis
of at least several species of parasitic nematodes and trematodes
(three of which are parasites of humans) [13,44,45] and in at least
one cestode, E. multilocularis [25]. The recent advances in
transgenesis offer some hope of reverse genetic analysis via gene
knockout. Other techniques that have been developed for
helminths are whole-mount in situ hybridisation and microarray
analyses [46–51], but their use is limited for functional analysis of
helminth-encoded genes. We refer the readers to the recent review
on transgenesis and gene delivery routes in parasitic nematodes by
Lok [52].
Another field that will benefit from improved genomics and
bioinformatics and novel enabling technologies is parasite
population biology studies. In filarial species there have been
difficulties in developing microsatellite markers, but in other
species, such as in schistosomes, the generation and use of
microsatellites has helped to understand transmission structuring
in parasite populations according to environment and host species
[53–55], as well as changes in genetic diversity under treatment
[56,57]. Population genetic studies of Ascaris have helped to
understand transmission patterns within and between A. lumbri-
coides and A. suum [58]. Without a robust understanding of parasite
population structure, it will be difficult to assess the short- and
long-term evolutionary implications of anthelmintic interventions
in general and chemotherapeutic pressure in particular. The few
population genetic studies of helminths conducted to date suggest,
not surprisingly, that the nature of the parasite’s life cycle (i.e.,
direct or indirect transmission; transmission via biting arthropods
or snails; single or multiple definitive hosts, etc.) has a very
significant impact on parasite population genetics [59]. Further-
more, the population genetics of a given species may be different
under different circumstances (e.g., schistosome populations in
different epidemiological settings show different genetic structure
[54,60]). Mathematical modeling suggests that differences in
population structure will affect transmission and, importantly,
the selection and spread of drug resistance alleles (we refer the
readers to Basa ´n ˜ez et al. [61] in this collection for a discussion of
these aspects).
The major challenge here is that despite the acknowledged
importance of parasite population biology and population genetics
for understanding parasite transmission, relevant data are sparse
for most helminth species. This is especially problematic when
Box 3. Functional Genomic Tools and
Helminth Research
Functional genomic tools fall into two broad categories: 1)
bioinformatic tools for sequence mining to generate
hypotheses concerning likely biological function, and 2)
experimental tools with which gene expression can be
manipulated in the target organism (or, in the case of
parasites, also the host) and the consequences of that
manipulation for the biology of the parasite and its
relationship with the host can be observed and measured.
The first bioinformatic tools that are applied are generally
genome-wide homology searches, usually using variants of
basic local alignment search tool (BLAST) to generate
automatic annotations based on sequence homology.
While perhaps useful as a tool with which to assess genome
content, homology-generated gene annotations are at best
a very rough guide and at worst downright misleading.
Additionally, in parasites the limited utility of a homology-
based approach is undermined further by the poor
performance of gene-finding software in parasite genomic
sequences. Nonetheless, several relatively advanced bioin-
formatic tools with which, for example, functional classes
can be grouped or putative metabolic pathways predicted
have been published recently along with examples of their
application [27,167]. These could be used to, for example,
search for likely differences between the parasite and its
host that may offer the opportunity for either vaccine or
drug development, or to search for molecules that may
mediate host pathology [13]. Allied to these bioinformatic
toolsisthe dramaticincreaseinsequencingcapacitysuchas
deep ‘‘whole transcriptome’’ sequencing, which yields
quantitative as well as qualitative data on parasite gene
expression. These data will aid in gene finding and
annotation as well as point to key regulatory events in the
parasites’ relationship with the host.
The most important functional genomic tool with which
gene function can be investigated is RNA interference,
whereby gene expression is knocked down by exposing
the parasites to gene-specific dsRNA or siRNA. Unfortu-
nately, the efficiency of RNAi in helminths varies between
species [28]. Problems often arise with the efficiency,
specificity and reproducibility of some methodologies,
especially with nematode species. This clearly highlights
the need for future research to optimise the delivery
methods and culture systems of these parasites. More
recently, transgenesis was established in some helminths
whereby a transgene was introduced, both transient and
heritable. At the moment, this is still used to overexpress
certain transgenes, but in the long term it is hoped that
this methodology can be used to silence genes by the
introduction of antisense transgenes.
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MDA on parasite populations, their structure and reproductive
biology, the incidence of new infections and how this may be
affected by the relaxation of any regulatory processes that may
operate (including acquired immunity), and the potential for the
selection and spread of resistant genotypes [59]. Once again, the
experience from malaria, where the phenomena of drug resistance
selection and its spread are well recognised, suggests that the
development of tools with which to promptly monitor drug
resistant genotypes, and deploy opportunely appropriate strategies
in response to such selection, require detailed knowledge of
parasite population structure and genetics. Acquisition of this
knowledge for helminth parasites must be given high priority.
Therefore, it is important that genome sequencing resources be
applied also to the investigation of parasite population genetic
structure, and the testing of predicted patterns of population sub-
division and gene flow.
Research funding for translational basic research will follow the
development of tools with which fundamental questions cannot
only be posed, but also answered. What is required is ‘‘seed’’
funding to develop the genomic resources. The genomic data
becoming available for schistosomes could have a major impact in
the medium and long terms [22] provided that similar, effective
functional genomic tools are developed for other helminths
(especially for nematodes).
2) Parasite Immunology
Parasites and hosts interact primarily via the host immune
system. Work over the past several years in parasite immunology,
mainly in rodent models, has focused to a large extent on the
identification of mechanisms of protective immunity that could
shed light on helminth vaccine development, but the emerging
theme in basic research is the realisation that the host–parasite
immunological relationship is highly interactive, and that
helminths are masterful immunoregulators [62,63]. Immune
regulation by parasites includes suppression, diversion, and
alteration of the host immune response. Numerous studies have
indicated that helminth-secreted proteins, glycoproteins, and lipid-
based molecules can interfere with various arms of the host
immune response, ultimately leading to the generation of an
environment favourable to the parasites’ survival [64–66]. Some of
the processes affected include the development of allergic
responses and interference with host cytokine regulation and
signal transduction networks [67–69]. These findings highlight the
complexity of helminth immunobiology with respect to the host–
parasite interaction, which is further complicated by polyparasit-
ism and potential inter-specific interactions, either by other
helminths of the same or different groups, protozoan parasites,
bacterial infections, or viral infections. Helminths have evolved to
co-adapt with their hosts and to evade/subvert powerful host
defense mechanisms, and it is these intricate interactions and
evolutionary trade-offs that have made them such successful
pathogens.
A characteristic feature of helminth infection is a T helper 2
(Th2)-dominated immune response, but stimulation of immuno-
regulatory cell populations, such as regulatory T cells and
alternatively activated macrophages, is equally common. Typical-
ly, Th1/Th17 immunity is blocked and productive effector
responses are muted, allowing survival of the parasite in a
‘‘modified Th2’’ environment. Successful immunoregulation also
limits collateral damage to the host. The remarkable range of
helminth life histories, transmission strategies, and physiological
niches is reflected in the variety of immunomodulatory activities
targeting key receptors or pathways in the mammalian immune
system observed across the three taxa of nematodes, cestodes, and
trematodes that comprise the helminth grouping [63]. However,
the mechanisms that initiate and sustain this immune regulation
remain incompletely understood. These immunoregulatory mech-
anisms are important not only in the context of explaining the
characteristic chronic infections, the absence of protective
immunity after first infection, and the difficulties faced in the
attempts of developing anti-helminthic vaccines [70], but also for
the evaluation of MDA and other treatment programmes.
Chemotherapy-based programmes can alter the dynamics of
transmission and the burdens of infection in treated communities
and are therefore likely to perturb these immunoregulatory
relationships, and thus have the potential to reverse these
immunoregulatory effects. This change could also have unintend-
ed consequences for global elimination efforts, such as increased
susceptibility to infection or to patency; increased disease burden
in children (who would not have developed tolerising immune
responses elicited by exposure to parasite antigens in utero, in
contrast to their counterparts prior to control [71]; or increased
morbidity due to the targeted helminth and/or other concurrent
infections. Also, the strength and duration of immune responses
are unknown, making it difficult to implement immunity-explicit
mathematical models that could help predict the impact of
anthelmintic treatment on reinfection and immunity parameters
[61,72].
The unintended immune consequences of treatment or other
interventions destined to reduce infection load and/or incidence
are not limited only to the targeted helminth infection. There is
increasing evidence of the importance of co-infections, in which
parasites and pathogens could interact in a synergistic or
antagonistic fashion. Suppressing or removing one parasite species
could give selective advantages to others by decreasing immune-
mediated competition or inhibitory effects. For example, it has
been proposed that individuals infected with parasitic helminths
have increased susceptibility to malaria infection [73,74], and that
helminth infections may also alter susceptibility to clinical malaria
[75,76]. There is now increasing interest in investigating the
consequences of such co-infection [77] and assessing whether mass
deworming affects the incidence of clinical malaria or other
infections, and such studies should be encouraged.
Concurrent helminth infections have been also shown to alter
optimal vaccine-induced responses in the human host; however,
the consequences of this condition have not been adequately
studied, especially in the context of an infection following
vaccination. Demands for new and effective vaccines to control
chronic diseases like tuberculosis, HIV, and malaria as well as
deploying vaccines for the so-called childhood diseases to all in
Africa require a systematic evaluation of confounding factors that
may limit vaccine efficacy, such as the presence of co-infections
with helminths in the populations of humans targeted for
vaccination. The bias towards a Th2 cytokine milieu induced by
helminth infection, especially the notable depression of gamma
interferon (IFN-c), which is pivotal in cellular immune responses,
has been compared to an ‘‘anti-adjuvant’’ effect [78]. It has been
shown that the presence of helminths may alter host responses to
bystander antigens like the tetanus toxin vaccines [79–82],
probably due to polarisation of the immune response to a Th2-
like response or the production of immunomodulating cytokines
like interleukin (IL)-10 that dampen both Th1 and Th2 responses.
The reduced response to the oral cholera vaccine observed in
individuals with A. lumbricoides could be, however, restored by
albendazole treatment [81]. The potential impact of helminth
infections on novel tuberculosis and malaria vaccines trials will
have to be considered [83,84].
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anthelmintics currently being used are not totally curative, and
numerous rounds of MDA may be necessary to reduce the levels of
infection below those necessary to sustain transmission [85]. Thus,
it can be anticipated that such major alterations in the levels of
infection in endemic communities might have a dramatic impact
on the degree of their immunity to the targeted parasites and other
co-infections, resulting in either a higher degree of protection
against re-infection (thereby promoting success of the MDA), or
conversely, resulting in less protection (and becoming a potential
impediment to elimination). For example, studies in humans and
cattle have shown that Onchocerca-infected hosts, in which infections
were cleared by chemotherapy, acquired new infections of equal
or higher intensity than those exhibited before the therapeutic
intervention [86–88]. Therefore, for example, in areas where
MDA with ivermectin does not result in transmission interruption,
those who are re-infected might develop a higher burden of
infection. Similar data exist for schistosomiasis and STHs [89–93].
A better understanding of the host–parasite immune relationships
at play at the molecular level and at different life cycle stages
within the host is thus important not only to make more precise
predictions about the eventual success of the specific elimination
efforts, but also to alert the MDA programmes of potential
problems that might arise from altered immunity in treated
communities.
3) (Vertebrate) Host–Parasite Interactions and
Pathogenesis
Host responses to helminth parasites are important factors in
disease manifestation. Typically, pathological characteristics may
manifest initially as acute reactions that may be followed by
chronic inflammation that results in significant immunopathology:
much of the disease is due to the host’s response to the presence of
the parasite rather than the direct action of the parasite. Primary
infection in naı ¨ve hosts often results in acute disease manifestation.
For some parasites, as the infection moves from the initial acute
phase to a chronic phase, inflammatory responses may resolve,
leaving many patients asymptomatic, but in a proportion of
patients (which varies in different host–parasite relationships) the
acute initial phase is followed by chronic inflammation. These
chronic inflammatory responses often do little or no damage to the
parasites, and in the case of penetration of the eggs of S. mansoni
through the intestinal wall, are actually exploited by the parasite to
its advantage. Modulation of host immune responses by the
parasites is a likely explanation for many of these phenomena, but
the details of the transition from acute to asymptomatic versus
chronic inflammation are generally unknown. The following
sections summarise current knowledge on the pathogenesis of the
infections under the remit of the DRG4 [3].
Onchocerciasis and lymphatic filariasis (LF). In
onchocerciasis, the interaction between O. volvulus and the host’s
defence system is vital to the individual’s tolerance of the infection.
Children born to mothers with O. volvulus had not only a
substantially higher risk of becoming infected, but also acquired
infection earlier in life and developed higher infection levels [94].
Different immune responses to O. volvulus cause considerable
variation in the clinical manifestations of human onchocerciasis,
from generalised to hyper-reactive onchocerciasis [95].
Onchocercal lesions result from inflammatory reactions involving
immunological mechanisms. The role of the immune system in the
pathology is demonstrated by the accelerated worm destruction
(microfilarial stages) during microfilaricidal chemotherapy.
Microfilarial destruction can be mediated by antibodies to the
surface-associated antigens of the worm and enhanced by
complement.
O. volvulus and the lymphatic filariae harbour intracellular
Wolbachia bacteria, now recognised as obligatory endosymbionts
essential for reproduction and survival of the worms, and therefore
emerging as novel targets for chemotherapy [96]. The presence of
Wolbachia may also be involved in immune evasion by the worms
[97], but on the other hand, it has also been implicated in the
immunopathogenesis of filarial infections [97–101]. Inflammatory
responses following treatment of filarial infections with diethylcar-
bamazine or ivermectin have been suggested to result in part from
the release of high numbers of endobacteria from degenerating
blood or tissue microfilariae (mf) [102,103]. Wolbachia and their
products are reported to elicit pronounced innate immune
responses in vitro consistent with those observed previously in
treated filariasis patients [104–108]. Interestingly, differences in
Wolbachia abundance between the savannah and forest forms of O.
volvulus may help explain differences in ocular pathogenicity [109].
Now that both genomes and excretory-secretory (ES) proteomes of
B. malayi and its Wolbachia are known [16,110,111], future studies
will help to further understanding of Wolbachia’s role in
pathogenesis prior to and after the introduction of MDA.
Soil-transmitted helminthiases (STHs). Although the
pathology due to these intestinal nematode infections is relatively
well known (see the excellent seminar in [112]), the pathogenesis
and pathogenic mechanisms of most STH infections have
remained poorly elucidated. The number of specific virulence
factors identified for each of the major parasite species is very
scanty. Moreover, for those specific parasite genes and gene
products thought to be important in infection and/or
pathogenesis, it has been difficult to demonstrate a definitive
role due to the inability to reliably silence gene expression in vitro
or in vivo. Some advances have been made in understanding the
role of human host genetics in the predisposition to STH infection
[113,114], and possibly these factors could also play a role in
disease manifestations. This is therefore an area that requires
further research efforts.
Schistosomiasis and other trematode infections. Exacer-
bation of host pathology occurs in a certain number of individuals
with schistosomiasis, and this may be explained by host genetics/
immunogenetics. In chronic schistosomiasis, severe hepatosplenic
pathology occurs in less than 10% of the infected population. The
pathology is characterised by excessive deposition of collagen and
other extracellular matrix components around schistosome egg
granulomas in the liver, causing periportal fibrosis and progressive
occlusion of the portal veins [115]. In murine schistosomiasis, the
pathology is induced by a CD4+ Th2-driven granulomatous
response directed against schistosome eggs lodged in the host liver.
The Th2 cytokines IL-4 and IL-13 drive this response, whereas IL-
10, IL-13Ra2, IFN-c, and a subset of regulatory T cells act to limit
schistosome-induced pathology. A variety of cell types including
hepatic stellate cells, alternatively activated macrophages, and
regulatory T cells have also been implicated in the pathogenesis of
schistosomiasis. Current knowledge suggests the immunopath-
ogenic mechanisms underlying both urinary and intestinal
schistosomiasis are likely to be similar [116]. Interestingly, a recent
study has reported lower liver morbidity and higher bladder
morbidity in mixed S. mansoni–S. haematobium infections compared
tosingleS.mansoni infections,possiblyexplained bythe localisationof
the hybridising adults (S. haematobium males mating with S. mansoni
females and the subsequent [infertile] eggs produced from such
couplingspassingtotheurinaryovipositionsite,therebyreducingthe
amount of classical S. mansoni–induced morbidity whilst increasing
the classic S. haematobium–associated bladder morbidity) [117].
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the susceptibility to and outcome of schistosome infections [118–
120]. For example, segregation analysis of a Brazilian population
has revealed that susceptibility to infection is controlled by the
SM1 (S. mansoni 1) gene locus that has been linked to the 5q31–q33
chromosome region comprising the genes for IL-4, IL-5, and IL-
13 [121,122]. Another study involving a Sudanese population
indicated that the segregation of a co-dominant gene (SM2) could
account for the familial distribution of severe S. mansoni
schistosomiasis in this population. Linkage analysis indicated that
this gene occurred within the 6q22–q23 region with polymor-
phisms close to and in the IFN-c receptor 1 gene (IFNGR1) [118].
A better understanding of factors that influence infection,
pathology, and protection is needed.
Other liver flukes (Fasciola hepatica, Opisthorchis spp., and Clonorchis
sinensis) use their suckers (oral and ventral) in hooking on biliary
epithelium, causing ulceration, for nutrition and migration [123–
125]. Fasciola proteases, some of which are developmentally
regulated, can degrade host tissue and blood, and form abscesses
during different migration phases, including intestinal wall or liver
penetration [123,126].
In other trematodiases, severe fibrosis of affected tissue/organs
is also a hallmark of chronic infection in certain individuals.
Advanced periductal fibrosis around the intra-hepatic bile ducts in
people with Op viverrini is associated with elevated parasite-specific
IL-6 production among 11 Th1/Th2 cytokines, in comparison to
those with no or minimal fibrosis [127]. Moreover, the fibrosis
occurs in a small subset of infected populations. Detailed studies on
molecular pathogenesis mechanisms of the liver fluke trematodes
need to be conducted (see for instance Smout et al. [128]).
Cestode infections. Cysticercosis, caused by Taenia solium
larvae, is a major public health problem, especially in the
developing world, and neurocysticercosis (NCC) is considered to
be the most common parasitic infestation of the central nervous
system [129,130]. Approximately 25% to 50% of active epilepsy
cases in the developing world, including India and Latin America,
are due to NCC [131]. NCC induces neurological syndromes that
vary from an asymptomatic infection to sudden death.
Neuroimaging is the mainstay of diagnosis. The genome project
of T. solium has been started [132] and knowledge of the genetic
structure of T. solium is being applied to studies on the
epidemiology, transmission, and pathogenicity of this disease
[133]. Studies on innate and acquired immune responses in
human T. solium NCC, which can persist for decades, have
highlighted conditions that appear to be favourable for the survival
or destruction of the parasite and for the benefit or injury to its
host [134]. In addition, animal models for the immunology of
cysticercosis in T. crassiceps infecting mice and T. solium infecting
pigs add more information on immune regulation of cysticercosis.
The parasite manipulates the host immune system to support its
survival by keeping a low inflammatory profile caused by the
production of some cysticerci-released products that have
immunomodulatory activities [135–137]. Moreover, the mouse
model has been used to design vaccine strategies, some of them
with promising results [135]. Further research is needed to
elucidate the role of the host’s immune response in 1) developing
an acute inflammatory response around the parasite, which is
strongly associated with symptoms, and seems to mark the onset of
the process of parasite death [138]; 2) developing peri-lesion
oedema in old, calcified lesions (this is also strongly correlated with
new symptomatic episodes) [139,140]; and 3) controlling and
eliminating infection, most likely in mildly exposed individuals
[141]. Importantly, the mechanisms used by the parasite to
modulate the host’s immune system at the central nervous system
level, and which allow its survival for years, also needs to be
studied [136,137].
Helminths as Group 1 carcinogens. In contrast to the view
that helminth infections are generally associated with morbidity
rather than mortality, the most severe pathology associated with
some helminth infections is cancer. Chronic infections with Op.
viverrini and C. sinensis, the Asian liver flukes, have long been
associated with cholangiocarcinoma or bile duct cancer [125,127],
and experimental studies on the proliferative effects caused by E-S
products of these species provide clues as to the mechanisms
involved [142–144]. Analysis of transcriptomic datasets of C.
sinensis and O. viverrini for proteins common to carcinogenesis
identified a large number of proteins that are homologues of genes
involved in human cancer development [25,145]. It is anticipated
that these transcriptomes will contribute significantly to the
identification of novel intervention tools.
Helminth-associated cancer is, however, not restricted to Asian
liver fluke infections. The eggs of S. haematobium provoke
granulomatous inflammation, ulceration, and pseudopolyposis of
the bladder and ureteral walls. Chronic lesions can then evolve
into fibrosis, and carcinoma of the bladder (squamous cell
carcinoma) [146]. All three of these helminth parasites have been
designated as Group 1 carcinogens—metazoan parasites that are
carcinogenic to humans—by the International Agency for
Research on Cancer of the World Health Organization.
Therefore, not only do these trematodes cause pathogenic
helminth infections, but they also are carcinogenic in humans in
a similar fashion to several other more well-known biological
carcinogens, in particular hepatitis viruses, human papilloma
virus, and Helicobacter pylori. Similarly, live filarial parasites or
filarial antigens induce significant human lymphatic endothelial
cell (LEC) proliferation. Moreover, serum from patently infected
(mf-positive) patients and those with longstanding chronic
lymphatic obstruction induced significantly increased LEC
proliferation compared to sera from uninfected individuals
[147]. Live, intact S. mansoni eggs secrete a soluble factor that
stimulates human umbilical vein endothelial cell proliferation
(HUVE) in vitro in a manner similar to crude soluble egg antigen
[148]. So overall, several helminth proteins possess mitogenic
effects on a variety of cells and may directly induce cell
proliferation. However, the number of studies performed to
unravel the mechanisms underlying the pathology seen in
helminthiases such as lymphangiogenesis (LF), neovascularisation
(schistosomiasis), or biliary proliferation and carcinogenesis
(opisthorchiasis and clonorchiasis) are limited [128,144,149,150].
4) (Invertebrate) Host–Parasite Interactions and
Transmission Biology
Recent advances in transmission biology have been partly
reflected in the development of mathematical models for parasite
population and transmission dynamics (see Basa ´n ˜ez et al. in this
collection [61]). Of all the helminthiases considered under the
remit of DRG4 (see [3]), filarial nematode and trematode
infections are the ones with complex life cycles involving a vector
or a snail host, respectively. (Other complex cycles, including
nematode life cycles that require molluscan hosts, are those of
Angiostrongylus cantonensis, for instance, and other complex develop-
mental cycles occur in other taxa such as T. solium, Gnathostoma
spinigerum, and Capillaria philippinensis. Of the latter, only T. solium is
under our remit, requiring a mammalian intermediate host.) This
interface is not of trivial importance given the close biological
association that exists between the parasites and their invertebrate
hosts. Yet, vector/intermediate host–parasite interactions are
usually under-appreciated, though they may hold the key to many
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Vector–filaria interactions. For the filariases, the issues
involved are ingestion of the skin- or blood-dwelling mf, their
survival anddevelopmentinto infectivethird-stagelarvae(L3) (there
is no multiplication of the parasite within the vector), and, in
common with all vector-borne diseases, survival of the vector until
completion of the extrinsic incubation period and beyond. These
processes have been investigated from genetic, immunological,
physiological, and ecological perspectives in an effort to understand
the basis for susceptibility/refractoriness to the parasites by the
corresponding arthropod taxa (e.g., mosquitoes in LF, blackflies in
onchocerciasis), and the close association between vector biting
behaviour and the availability of mf to be ingested from blood or
skin. From a population biology point of view, some of these
underlying processes translate into relationships between
consecutive parasite life stages that are of interest for
epidemiological models. Some of these relationships (e.g., the
numberofO.volvulusorW.bancroftiL3larvae perflyorpermosquito
as a function of the microfilarial load on which the insects were fed)
may be nonlinear, indicating the operation of density dependence
[151,152]. It is apparent that density-dependent processes regulate
parasite population abundance and their effect is relaxed as a result
of anthelmintic treatment, leading to enhanced per parasite
probabilities of transmission. Therefore, an understanding of
vector–parasite interactions becomes even more crucial as control
programmes progress from morbidity reduction to elimination
goals. Also, in some settings, there may be various vector–parasite
combinations whose features may be impacted differently by
interventions (e.g., differential effects of antivectorial measures
depending on whether vector species feed and rest indoors or
outdoors, or have a propensity to feed on humans or non-human
blood hosts). (See Griffin et al. [153] for a theoretical exploration of
malaria transmission in Africa, but similar issues will arise, and will
need research in LF, particularly where both infections are
transmitted by the same Anopheles vectors.)
Very few of the vector–filaria combinations have been char-
acterised in detail, including studies of geographical distribution,
ecological requirements of insects’ aquatic and adult stages, vector
competence, vectorial capacity, and local adaptation, among others.
Without these studies, detailed mapping of the distribution of vectors
and parasites will remain elusive. Vector competence encompasses
the processes by which the vectors locate, ingest, and allow the
parasites to complete their extrinsic incubation period. For vectors to
transmit, they not only must survive such a period but also beyond it
(the so-called infective life-expectancy or longevity factor in vector-
borne diseases) [154]. In general, these processes remain poorly
characterised and quantified in those vector–filaria combinations
that are responsible for transmission in endemic areas. Some effort
has been placed in doing so for Simulium–Onchocerca complexes given
the impetus of the former Onchocerciasis Control Programme in
West Africa (OCP) and the need to quantify such relationships for
their use in mathematical models [151]. Likewise, and in order to
explore the likelihood of elimination in LF settings, statistical
descriptions of mosquito–Wuchereria interactions have received
attention [155,156]. Less is known about natural mosquito–Brugia
and tabanid–Loa interactions, knowledge of which relies on old
descriptive studies that, although still relevant, would need to be
updated and expanded. Vector competence studies should be
complemented by vectorial capacity investigations. Vectorial
capacity (a close relative of the basic reproduction ratio in vector-
borne diseases) also includes factors such as vector to host ratio,
vector biting rate on humans, the propensity of vectors to feed on
human or non-human blood hosts, vector mortality, and any
seasonaland/orspatialdependenciesthatmayoccurinthesefactors.
Knowledge of these, as well as of any density dependence that may
operate (e.g.,on the densityofvectors and/or hosts,on the density of
parasites), will inform design and implementation of vector control
and any transmission-blocking intervention that may be developed.
Yet, knowledge is still very scarce as to if and how helminth parasites
manipulate these crucial aspects of the interaction. There is
increasing evidence that this is the case in malaria, but experimental
and observational studies in filariasis have lagged behind. It will also
be of great interest to conduct research on how the Wolbachia
symbionts of arthropod vectors and the Wolbachia symbionts of the
filarial nematodes influence the competence of the vectors and the
transmission biology of the parasites.
Snail–trematode interactions. Schistosome transmission
occurs via free-swimming larval stages, cercariae, infective to
mammalian definitive hosts, and miracidia, infective to the
molluscan intermediate hosts. These non-feeding larvae obtain
their energy through limited glycogen reserves, so there are strong
selective pressures to locate and penetrate a suitable host rapidly
post-emergence. Some of the snail–parasite issues in the
schistosome life cycle are similar to those of filariases, highlight-
ing the importance of parasite survival and development into the
infective stage, and the survival of the intermediate host. In
addition, schistosome larvae must themselves locate their subse-
quent hosts and asexually reproduce within the snail. Schistosome
miracidia have evolved effective snail-seeking behaviours
[157,158], e.g., S. mansoni miracidia show geonegative and
photopositive responses whereas S. haematobium show geopositive
and photonegative responses, directing them, respectively, towards
their contrasting Biomphalaria glabrata and Bulinus globosus snail host
habitats. Young/recently hatched miracidia of ,1–3 hours exhibit
dispersal strategies rather than host attraction [159], potentially
limiting density-dependent constraints occurring in the snail hosts.
Density trade-offs appear to occur throughout the parasites’ life
cycle [160]. Miracidia have also been demonstrated to show
sympatric specificity for host location [161] and penetration [162].
Once successful penetration of a suitable snail host has occurred,
schistosomes undergo migration, asexual reproduction, and emer-
gence of cercariae whilst evading the snail’s immune response.
Trade-offs often occur between daily cercarial production and host
longevity,life-historytraits, andvirulence,with lowerdaily shedding
associated with higher host survival and longer infectivity [160].
Intra- and inter-specific interactions also affect life-history respons-
es, with S. mansoni mixed-strain infections inducing greater snail
mortality in comparison to single-strain infections [163].
Cercarial emergence can vary in its chronobiological rhythm to
maximise the chances of encountering a suitable definitive host.
These interactions are also affected by inter-specific and intra-
specific variation [164]. Lu et al. [165] have shown that in S.
japonicum, which can infect up to 40 definitive host species,
cercarial emergence from rodent infections peak at dusk and
dawn, when their hosts are most active, whilst cercarial emergence
for bovine strains peaks at noon.
Schistosome snail hosts are hermaphroditic, so even with intense
mollusciciding or drought, they can still repopulate from extremely
low numbers. However, the host-specificity shown by the Egyptian
strains may have contributed to explaining why mollusciciding
alongside mass praziquantel treatment was successful, with no
long-term resistance emerging within Egypt [166]. Thus, an
understanding of snail–schistosome interactions may be crucial for
identifying optimal control mechanisms.
Regarding the snail–trematode interactions, most of the efforts
have been made for the schistosomes as described above, but the
literature on the ecological, evolutionary, and epidemiological
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reportand their snail hosts issparse. It would seem that the reference
to ‘‘food-borne trematodiases’’ (because of the nature of the
subsequent intermediate hosts for these parasites) has somewhat
decreasedtheimportanceoftheirfirst,snailhosts.Yet,itiswithinthe
snail hosts that many important processes allowing the asexual
multiplication of the parasite take place. Unlike schistosomes, the
eggs of Clonorchis and Opisthorchis are eaten by the snail hosts (rather
than the miracidia locating and invading the snails), but the resulting
cercariae also need to find and locate their second intermediate,
freshwater fish host. These are not just passive transport hosts of the
parasites as it is in the fish that the metacercariae (the stages infective
by digestion of raw, undercooked fish) develop. Therefore, the study
of the host–trematode interactions for these infections must include
those taking place in the snails and the vertebrate intermediate hosts.
Difficulties in maintaining theentirelifecycle ofthese parasitesinthe
lab would certainly impose constraints on experimental studies such
as those conducted for schistosomes.
Concluding Remarks and Recommendations
From the discussion above, we propose an R&D agenda for
basic helminth biology that is summarised in Box 4 and expanded
in Text S1. This R&D agenda will support the development of
new intervention tools and control measures for helminth
infections. It is our contention that the success of present and
future intervention programmes will require basic research that
will help to bridge the gap between the bench, the clinical and
population-based research studies, and the operational pro-
grammes. The recent research landscape for helminth parasites
has been dominated by rapid progress in genome sequencing of
several nematode and trematode parasites of significance to
human disease. Future genome-wide analyses will support efforts
to elucidate the basic biology of helminths, including immune-
mediated and other host–parasite interactions that are relevant to
helminth diseases of humans. They will help to develop novel
intervention strategies such as drugs and therapeutic or prophy-
lactic vaccines, as well as to identify parasite biomarkers and devise
improved diagnostics. As many of the helminth infections are
transmitted by arthropod vectors or involve intermediate hosts, a
greater understanding of the interaction between vector/interme-
diate hosts and parasites is also important. Such research may be
useful to identify potential targets for parasite growth and survival
within the vector and transmission to the human host.
Supporting Information
Text S1 Recommendations to policy and decision makers:
identification of priorities for basic helminth research and the
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